Adial Pharmaceuticals, Inc. (ADIL)

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD04, a selective serotonin-3 antagonist that has completed Phase IIb clinical trials for the treatment of nausea and emesis. The company was founded in 2010 and is based in Charlottesville, Virginia.

Current Quote*
Last: $6.949
Change: -0.151
Book: $10.106
Volume: 371,106

As Of: 01/18 13:34 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol ADIL

Graphs for ADIL


3 Month Graph


6 Month Graph


1 Year Graph